| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
potassium voltage-gated channel subfamily Q member 2 | 0.537 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 29 | 1 | 1980 | 2017 | ||||||||
|
potassium voltage-gated channel subfamily A member 2 | 0.612 | 0.577 | 0.91 |
|
phenotype | 0.100 | None | 1.000 | 28 | 1 | 1991 | 2017 | ||||||||
|
ATPase Na+/K+ transporting subunit alpha 3 | 0.544 | 0.615 | 1.00 |
|
group | 0.100 | None | 1.000 | 27 | 1 | 1988 | 2017 | ||||||||
|
syntaxin binding protein 1 | 0.532 | 0.692 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 27 | 1 | 1998 | 2016 | ||||||||
|
zinc finger and BTB domain containing 18 | 0.666 | 0.500 | 1.00 |
|
group | 0.100 | None | 1.000 | 26 | 1 | 1997 | 2017 | ||||||||
|
homeobox B13 | 0.573 | 0.462 | 3.7E-08 |
|
group | 0.100 | None | 1.000 | 26 | 1 | 1996 | 2017 | ||||||||
|
fibroblast growth factor receptor 2 | 0.380 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 26 | 1 | 1985 | 2017 | ||||||||
|
SET domain containing 5 | 0.560 | 0.731 | 1.00 |
|
group | 0.100 | None | 1.000 | 26 | 1 | 1995 | 2018 | ||||||||
|
SET domain containing 5 | 0.560 | 0.731 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 26 | 1 | 1995 | 2018 | ||||||||
|
SET domain containing 5 | 0.560 | 0.731 | 1.00 |
|
disease | 0.120 | None | 1.000 | 26 | 1 | 1995 | 2018 | ||||||||
|
glutamate ionotropic receptor NMDA type subunit 1 | 0.561 | 0.692 | 0.98 |
|
group | 0.130 | None | 1.000 | 25 | 1 | 1983 | 2017 | ||||||||
|
BAF chromatin remodeling complex subunit BCL11A | 0.541 | 0.769 | 0.97 |
|
phenotype | 0.100 | None | 1.000 | 25 | 1 | 2000 | 2018 | ||||||||
|
BAF chromatin remodeling complex subunit BCL11A | 0.541 | 0.769 | 0.97 |
|
disease | 0.100 | None | 1.000 | 25 | 1 | 2000 | 2018 | ||||||||
|
lysine methyltransferase 2D | 0.465 | 0.808 | 1.00 |
|
group | 0.100 | None | 1.000 | 25 | 1 | 1988 | 2017 | ||||||||
|
lysine methyltransferase 2D | 0.465 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 25 | 1 | 1988 | 2017 | ||||||||
|
cullin 3 | 0.592 | 0.654 | 1.00 |
|
group | 0.100 | None | 1.000 | 25 | 1 | 1986 | 2016 | ||||||||
|
cullin 3 | 0.592 | 0.654 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 25 | 1 | 1986 | 2016 | ||||||||
|
histone deacetylase 3 | 0.511 | 0.731 | 0.57 |
|
group | 0.100 | None | 1.000 | 25 | 1 | 1999 | 2016 | ||||||||
|
transient receptor potential cation channel subfamily V member 4 | 0.457 | 0.808 | 2.2E-16 |
|
disease | 0.100 | None | 1.000 | 24 | 1 | 1976 | 2017 | ||||||||
|
clathrin heavy chain | 0.558 | 0.769 | 1.00 |
|
group | 0.100 | None | 1.000 | 23 | 1 | 1976 | 2017 | ||||||||
|
clathrin heavy chain | 0.558 | 0.769 | 1.00 |
|
group | 0.100 | None | 1.000 | 23 | 1 | 1976 | 2017 | ||||||||
|
clathrin heavy chain | 0.558 | 0.769 | 1.00 |
|
disease | 0.100 | None | 1.000 | 23 | 1 | 1976 | 2017 | ||||||||
|
dedicator of cytokinesis 3 | 0.619 | 0.692 | 1.00 |
|
group | 0.100 | None | 1.000 | 23 | 1 | 2000 | 2018 | ||||||||
|
dedicator of cytokinesis 3 | 0.619 | 0.692 | 1.00 |
|
disease | 0.100 | None | 1.000 | 23 | 1 | 2000 | 2018 | ||||||||
|
peptidyl-tRNA hydrolase 2 | 0.641 | 0.577 | 6.4E-04 |
|
group | 0.100 | None | 1.000 | 23 | 1 | 1976 | 2017 |